Bacterial clearance by antibiotic treatment in the lung

Mice infected intranasally with YS001, YS002, YS005, YS008, YS009, or YS010 were intragastically administered AMP, AZM, CLR, CFPN-PI, LVX (100 mg/kg/day), or methylcellulose (control) once (AZM) or three times (AMP, CLR, CFPN-PI, LVX, and methylcellulose) daily for three days after infection. On day 4 after infection, the mice were harvested, and bacterial loads were determined in lung homogenates. Data represent the means ± SD of five mice per group. *, < 0.05 (compared with control). **, < 0.01 (compared with control). ND, not detected.<p><b>Copyright information:</b></p><p>Taken from "Comparative efficacies of different antibiotic treatments to eradicate nontypeable infection"</p><p>http://www.biomedcentral.com/1471-2334/8/15</p><p>BMC Infectious Diseases 2008;8():15-15.</p><p>Published online 7 Feb 2008</p><p>PMCID:PMC2276502.</p><p></p>